Wnt2 is overexpressed in many stages of the development of colorectal cancer [25], and Wnt5a is overexpressed in breast cancer, colorectal cancer, lung cancer, prostate cancer and melanoma [26, 27]. This evidence concerns the gene WNT5A and lung carcinoma.